Front-line therapies for elderly patients with transplant-ineligible multiple myeloma and high-risk cytogenetics in the era of novel agents.

21 janvier 2020  | Publications

Avet-Loiseau H, Facon T.      

https://www.ncbi.nlm.nih.gov/pubmed/29720731      

---

RETOUR AUX ARTICLES PUBLICATIONS

---